Literature DB >> 27110706

Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.

Jane Murphy1, William W Hall1, Lee Ratner2, Noreen Sheehy1.   

Abstract

The human T-cell leukaemia virus type 1 and type 2 (HTLV-1/HTLV-2) antisense proteins HBZ and APH-2 play key roles in the HTLV lifecycles and persistence in the host. Nuclear Factors Associated with double-stranded RNA (NFAR) proteins NF90/110 function in the lifecycles of several viruses and participate in host innate immunity against infection and oncogenesis. Using GST pulldown and co-immunoprecipitation assays we demonstrate specific novel interactions between HBZ/APH-2 and NF90/110 and characterised the protein domains involved. Moreover we show that NF90/110 significantly enhance Tax mediated LTR activation, an effect that was abolished by HBZ but enhanced by APH-2. Additionally we found that HBZ and APH-2 modulate the promoter activity of survivin and are capable of antagonising NF110-mediated survivin activation. Thus interactions between HTLV antisense proteins and the NFAR protein family have an overall positive impact on HTLV infection. Hence NFARs may represent potential therapeutic targets in HTLV infected cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APH-2; HBZ; HTLV; NFAR; Survivin; Tax1; Tax2; YM155

Mesh:

Substances:

Year:  2016        PMID: 27110706      PMCID: PMC4924524          DOI: 10.1016/j.virol.2016.04.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  93 in total

1.  Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Authors:  Han Yin; Priya Kannian; Nathan Dissinger; Robyn Haines; Stefan Niewiesk; Patrick L Green
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.

Authors:  Reed S Shabman; Daisy W Leung; Joshua Johnson; Nicole Glennon; Erol E Gulcicek; Kathryn L Stone; Lawrence Leung; Lisa Hensley; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

3.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.

Authors:  J E Kaplan; M Osame; H Kubota; A Igata; H Nishitani; Y Maeda; R F Khabbaz; R S Janssen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

Review 4.  NF90 isoforms, a new family of cellular proteins involved in viral replication?

Authors:  Claudia Patiño; Anne-Lise Haenni; Silvio Urcuqui-Inchima
Journal:  Biochimie       Date:  2014-11-04       Impact factor: 4.079

Review 5.  Treat cancers by targeting survivin: just a dream or future reality?

Authors:  Mohane Selvaraj Coumar; Fang-Ying Tsai; Jagat Rakesh Kanwar; Sailu Sarvagalla; Chun Hei Antonio Cheung
Journal:  Cancer Treat Rev       Date:  2013-02-28       Impact factor: 12.111

6.  Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.

Authors:  Nancy L Guo; Ying-Wooi Wan; Kursad Tosun; Hong Lin; Zola Msiska; Daniel C Flynn; Scot C Remick; Val Vallyathan; Afshin Dowlati; Xianglin Shi; Vincent Castranova; David G Beer; Yong Qian
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

Review 7.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

8.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

9.  Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.

Authors:  Silvio Urcuqui-Inchima; Maria Eugenia Castaño; Danièle Hernandez-Verdun; Georges St-Laurent; Ajit Kumar
Journal:  Retrovirology       Date:  2006-11-24       Impact factor: 4.602

10.  YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

Authors:  Takahito Nakahara; Aya Kita; Kentaro Yamanaka; Masamichi Mori; Nobuaki Amino; Masahiro Takeuchi; Fumiko Tominaga; Shinji Hatakeyama; Isao Kinoyama; Akira Matsuhisa; Masafumi Kudoh; Masao Sasamata
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 13.312

View more
  7 in total

1.  The ESCRT-0 Protein HRS Interacts with the Human T Cell Leukemia Virus Type 2 Antisense Protein APH-2 and Suppresses Viral Replication.

Authors:  Fanny Martini; Coline Arone; Amy Hasset; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

Review 2.  Functional and Pathogenic Roles of Retroviral Antisense Transcripts.

Authors:  Kosuke Toyoda; Masao Matsuoka
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

3.  Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.

Authors:  Manraj Singh Narulla; Ahlam Alsairi; Lucie Charmier; Stephen Noonan; David Conroy; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

4.  Interleukin-2 enhancer binding factor 2 interacts with the nsp9 or nsp2 of porcine reproductive and respiratory syndrome virus and exerts negatively regulatory effect on the viral replication.

Authors:  Xuexia Wen; Ting Bian; Zhibang Zhang; Lei Zhou; Xinna Ge; Jun Han; Xin Guo; Hanchun Yang; Kangzhen Yu
Journal:  Virol J       Date:  2017-07-11       Impact factor: 4.099

Review 5.  Comparative virology of HTLV-1 and HTLV-2.

Authors:  Michael P Martinez; Jacob Al-Saleem; Patrick L Green
Journal:  Retrovirology       Date:  2019-08-07       Impact factor: 4.602

6.  HTLV-2 Encoded Antisense Protein APH-2 Suppresses HIV-1 Replication.

Authors:  Rajkumar Londhe; Smita Kulkarni
Journal:  Viruses       Date:  2021-07-23       Impact factor: 5.048

Review 7.  Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.

Authors:  Robert Harrod
Journal:  Retrovirology       Date:  2019-09-06       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.